Filter Results
:
(554)
Show Results For
-
All HBS Web
(554)
- People (1)
- News (211)
- Research (225)
- Events (1)
- Multimedia (11)
- Faculty Publications (139)
Show Results For
-
All HBS Web
(554)
- People (1)
- News (211)
- Research (225)
- Events (1)
- Multimedia (11)
- Faculty Publications (139)
- May 2016
- Article
How the Affordable Care Act Has Affected Cancer Care in the United States: Has Value for Cancer Patients Improved?
By: Stephen M. Schleicher, Nancy M. Wood, Seohyun Lee and Thomas W. Feeley
The Patient Protection and Affordable Care Act (ACA), passed in 2010, contained a number of provisions with potential to directly or indirectly affect cancer care. Value for patients was widely discussed throughout the bill, and the Centers for Medicare and Medicaid...
View Details
Schleicher, Stephen M., Nancy M. Wood, Seohyun Lee, and Thomas W. Feeley. "How the Affordable Care Act Has Affected Cancer Care in the United States: Has Value for Cancer Patients Improved?" Oncology 30, no. 5 (May 2016): 468–474.
- February 2003 (Revised August 2003)
- Teaching Note
Dana-Farber Cancer Institute, The (TN)
By: Richard M.J. Bohmer
Teaching Note for (9-699-025).
View Details
Keywords:
Health Industry
- August 2007 (Revised November 2008)
- Case
Biocon: Launching a New Cancer Drug in India
By: Sunil Gupta and Das Narayandas
Kiran Majumdar-Shaw, the CEO of Biocon has to make product launch timing, pricing, channel, and communications mix decisions relating to the launch of BioMAb, a new cancer drug in India.
View Details
Keywords:
Price;
Health Care and Treatment;
Marketing Strategy;
Product Launch;
Planning;
Biotechnology Industry;
Pharmaceutical Industry;
India
Gupta, Sunil, and Das Narayandas. "Biocon: Launching a New Cancer Drug in India." Harvard Business School Case 508-026, August 2007. (Revised November 2008.)
- Article
Time-Driven Activity-Based Costing in Breast Cancer Care Delivery
By: Navraj S. Nagra, Elena Tsangaris, Jessica Means, Michael J. Hassett, Laura S. Dominici, Jennifer R. Bellon, Justin Broyles, Robert S. Kaplan, Thomas W. Feeley and Andrea L. Pusic
We used time-driven activity-based costing (TDABC) to calculate the complete cost of breast cancer care—initial treatment planning, chemotherapy, radiation therapy, surgical resection and reconstruction, and ancillary services (psychosocial oncology, physical therapy....
View Details
Nagra, Navraj S., Elena Tsangaris, Jessica Means, Michael J. Hassett, Laura S. Dominici, Jennifer R. Bellon, Justin Broyles, Robert S. Kaplan, Thomas W. Feeley, and Andrea L. Pusic. "Time-Driven Activity-Based Costing in Breast Cancer Care Delivery." Annals of Surgical Oncology 29, no. 1 (January 2022): 510–521.
- May 1999 (Revised December 2007)
- Case
The Dana-Farber Cancer Institute: Development Strategy
By: V. Kasturi Rangan and Marie Bell
Despite revenues in excess of $93 million in 1998, world-renowned Dana-Farber Cancer Institute constantly faces an operating shortfall and looks to its highly successful development office to help cover the deficit. The development office raises money annually (with a...
View Details
Keywords:
Decision Choices and Conditions;
Capital;
Revenue;
Growth and Development Strategy;
Mission and Purpose;
Nonprofit Organizations
Rangan, V. Kasturi, and Marie Bell. "The Dana-Farber Cancer Institute: Development Strategy." Harvard Business School Case 599-104, May 1999. (Revised December 2007.)
- 2024
- Working Paper
Tamoxifen—Reducing Breast Cancer Risks: Case Histories of Transformational Advances
By: Amar Bhidé, Srikant Datar and Katherine Stebbins
We describe the development of tamoxifen, considered a “gold standard” treatment for
millions of breast cancer patients. Specifically, we describe breast cancer treatments before tamoxifen’s
development; the initial development of tamoxifen from 1960 to 1973;...
View Details
Keywords:
Health Care and Treatment;
Technological Innovation;
Innovation and Invention;
Innovation Strategy;
Technology Adoption;
Collaborative Innovation and Invention;
Governing Rules, Regulations, and Reforms
Bhidé, Amar, Srikant Datar, and Katherine Stebbins. "Tamoxifen—Reducing Breast Cancer Risks: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-134, July 2020. (Revised May 2024.)
- 12 Jan 2017
- News
What Cancer Researchers Can Learn from Direct-to-Consumer Companies
- 12 Feb 2019
- News
4 Important Steps to Take After a Cancer Diagnosis
- September 2011
- Article
A Cancer Center Puts the New Approach to Work: Pilot
By: Heidi W. Albright and Thomas W. Feeley
The University of Texas MD Anderson Cancer Center is a National Cancer Institute–designated Comprehensive Cancer Center, located in Houston, Texas. Seeing more than 30,000 new patients every year, MD Anderson accounts for approximately 20% of
cancer care within the...
View Details
Keywords:
Health Care;
Health Care Quality;
Measurement;
Costing;
Accounting;
Health;
Quality;
Health Industry;
North and Central America
Albright, Heidi W., and Thomas W. Feeley. "A Cancer Center Puts the New Approach to Work: Pilot." R1109B. Harvard Business Review 89, no. 9 (September 2011): 15–16. (This article is a sidebar description of a pilot of time-driven activity-based costing in the HBR article "How to Solve the Cost Crisis in Health Care" by Robert S. Kaplan and Michael E. Porter.)
- November 2012 (Revised February 2009)
- Teaching Note
The University of Texas MD Anderson Cancer Center: Interdisciplinary Cancer Care (TN)
By: Michael E. Porter and Sachin H Jain
Teaching Note for [708487].
View Details
Porter, Michael E., and Sachin H Jain. "The University of Texas MD Anderson Cancer Center: Interdisciplinary Cancer Care (TN)." Harvard Business School Teaching Note 709-482, February 2009. (Revised from original February 2009 version.)
- 05 Sep 2017
- News
Bargaining With Cancer Patients About Treatment
- December 2011 (Revised December 2011)
- Case
Cancer Treatment Centers of America: Scaling the Mother Standard of Care
By: Rosabeth Moss Kanter and Matthew Bird
The CEO of a private and growing national network of specialty care hospitals focusing on advanced-stage and complex cancer treatments reflected on the firm's past phase of growth before meeting with the company's Chairman and founder to discuss how to further scale...
View Details
Keywords:
Health Care and Treatment;
Business Growth and Maturation;
Medical Specialties;
Service Delivery;
Innovation and Invention;
Health Industry
Kanter, Rosabeth Moss, and Matthew Bird. "Cancer Treatment Centers of America: Scaling the Mother Standard of Care." Harvard Business School Case 312-073, December 2011. (Revised December 2011.)
- 15 Mar 2019
- News
Targeting cancer and careers: Precision Medicine
- February 2010
- Teaching Note
Koo Foundation Sun Yat-Sen Cancer Center: Breast Cancer Care in Taiwan (TN)
By: Michael E. Porter and Jennifer F Baron
Teaching Note for [710425].
View Details
- March 2014
- Article
Delivering High-quality Cancer Care: The Critical Role of Quality Measurement
By: Tracy Spinks, Patricia Ganz, George Sledge, Laura Levit, James Hayman, Timothy Eberlein and Thomas W. Feeley
In 1999, the Institute of Medicine (IOM) published Ensuring Quality Cancer Care, an influential report that described an ideal cancer care system and issued ten recommendations to address pervasive gaps in the understanding and delivery of quality cancer... View Details
Keywords:
Health Care Quality;
Health Care and Treatment;
Quality;
Measurement and Metrics;
Health Industry;
North America
Spinks, Tracy, Patricia Ganz, George Sledge, Laura Levit, James Hayman, Timothy Eberlein, and Thomas W. Feeley. "Delivering High-quality Cancer Care: The Critical Role of Quality Measurement." Healthcare: The Journal of Delivery Science and Innovation 2, no. 1 (March 2014): 53–62. (PMCID: PMC4021589.)
- 12 Dec 2018
- News
Impact Investing Could Accelerate the Fight Against Cancer
- August 17, 2016
- Article
How a Cancer Center Rapidly Developed Patient-Centered Outcome Measures
By: Kevin P. Shah, Tracy E. Spinks and Thomas W. Feeley
In 2014, The University of Texas MD Anderson Cancer Center created a streamlined process for developing measure sets for patient-centered outcomes, including provider-generated and patient-reported outcomes, at an accelerated pace. These comprehensive sets are...
View Details
Keywords:
Information Technology;
Measurement and Metrics;
Quality;
Service Delivery;
Health Care and Treatment;
Health Industry;
Texas
Shah, Kevin P., Tracy E. Spinks, and Thomas W. Feeley. "How a Cancer Center Rapidly Developed Patient-Centered Outcome Measures." NEJM Catalyst (August 17, 2016).
- June 2004 (Revised May 2005)
- Case
Judah Folkman and the War on Cancer
Judah Folkman, professor in the Division of Vascular Biology at Children's Hospital in Boston, is considering how best to advance the research in his lab in an era where biomedical research has gotten more interdisciplinary and collaborative. Specifically, Folkman has...
View Details
Keywords:
Conflict of Interests;
Leadership;
Research;
Personal Development and Career;
Health Care and Treatment;
Collaborative Innovation and Invention;
Biotechnology Industry;
Health Industry;
Boston
West, Jonathan, Ambuj Sagar, and Mona Ashiya. "Judah Folkman and the War on Cancer." Harvard Business School Case 604-091, June 2004. (Revised May 2005.)